ID

12175

Descrizione

A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation NCT00148148

Keywords

versioni (2)
  1. 06/10/15 06/10/15 -
  2. 06/10/15 06/10/15 - Martin Dugas
Caricato su

6 ottobre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0 Legacy
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

Tedesco Inglese

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

1 moduli  
Inclusion criteria
Descrizione

Inclusion criteria

Alias
UMLS CUI-1
C1512693
Adult Patient (>=18 years) with granulocytopenia (absolute number neutrophil: <=500 / ul) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
Descrizione

Adult Patient (≥ 18 years) with granulocytopenia (absolute number neutrophil: ≤500 / μl) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A

Tipo di dati

boolean

Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
Descrizione

Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A

Tipo di dati

boolean

Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
Descrizione

Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples

Tipo di dati

boolean

For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
Descrizione

For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation

Tipo di dati

boolean

Life expectancy ≥5 days
Descrizione

Life expectancy ≥5 days

Tipo di dati

boolean

Treatment in one of said test centers
Descrizione

Treatment in one of said test centers

Tipo di dati

boolean

Adequate renal and hepatic function in accordance with the following definitions
Descrizione

Adequate renal and hepatic function in accordance with the following definitions

Tipo di dati

boolean

Bilirubin Total: ≤ 3x upper reference value
Descrizione

Bilirubin Total: ≤ 3x upper reference value

Tipo di dati

boolean

SGOT or SGPT: ≤ 3x upper reference value
Descrizione

SGOT or SGPT: ≤ 3x upper reference value

Tipo di dati

boolean

Alkaline phosphatase: ≤ 5x upper reference value
Descrizione

Alkaline phosphatase: ≤ 5x upper reference value

Tipo di dati

boolean

Creatinine i. S.: ≤ 2x the upper reference value
Descrizione

Creatinine i. S.: ≤ 2x the upper reference value

Tipo di dati

boolean

Written informed consent of the patient or the legal representative
Descrizione

Written informed consent of the patient or the legal representative

Tipo di dati

boolean

Exclusion criteria
Descrizione

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Participate in this study at an earlier date
Descrizione

Participate in this study at an earlier date

Tipo di dati

boolean

Serious psychiatric pre-/concomitant disease
Descrizione

Serious psychiatric pre-/concomitant disease

Tipo di dati

boolean

Pregnancy or lactation
Descrizione

Pregnancy or lactation

Tipo di dati

boolean

Women of childbearing age with insufficient or unsecured contraception
Descrizione

Women of childbearing age with insufficient or unsecured contraception

Tipo di dati

boolean

Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
Descrizione

Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)

Tipo di dati

boolean

Patient with pathological function parameters of liver and kidney function
Descrizione

Patient with pathological function parameters of liver and kidney function

Tipo di dati

boolean

Total bilirubin:> 3x upper reference value
Descrizione

Total bilirubin:> 3x upper reference value

Tipo di dati

boolean

SGOT or SGPT:> 3x upper reference value
Descrizione

SGOT or SGPT:> 3x upper reference value

Tipo di dati

boolean

Alkaline phosphatase:> 5x the upper reference value
Descrizione

Alkaline phosphatase:> 5x the upper reference value

Tipo di dati

boolean

Creatinine i. S.:> 2x upper reference value
Descrizione

Creatinine i. S.:> 2x upper reference value

Tipo di dati

boolean

Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
Descrizione

Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites

Tipo di dati

boolean

Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
Descrizione

Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days

Tipo di dati

boolean

Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
Descrizione

Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine

Tipo di dati

boolean

Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
Descrizione

Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B

Tipo di dati

boolean

Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
Descrizione

Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study

Tipo di dati

boolean

Missing or incomplete consent
Descrizione

Missing or incomplete consent

Tipo di dati

boolean

Ritorna all'inizio della pagina

Similar models

Inclusion and exclusion criteria Stem-Cell Transplantation CASLAMB NCT00148148

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Adult Patient (≥ 18 years) with granulocytopenia (absolute number neutrophil: ≤500 / μl) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
Item
Adult Patient (>=18 years) with granulocytopenia (absolute number neutrophil: <=500 / ul) and allogeneic hematopoietic condition after Stem cell transplantation and immunosuppression with cyclosporine A
boolean
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
Item
Patient with persistent or relapsed fever (oral temperature ≥38.0°C) and granulocytopenia (absolute Neutrophil Count ≤500 / μl) and adequate antibacterial therapy for ≥36-48 Hours in need of empirical antifungal therapy A
boolean
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
Item
Reclining, at least double-recurrent central venous catheters for administration of drugs and for the extraction of plasma samples
boolean
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
Item
For patients of childbearing age: existence of a negative Pregnancy tests within 7 days prior to initiation of treatment and adequate contraception during study participation
boolean
Life expectancy ≥5 days
Item
Life expectancy ≥5 days
boolean
Treatment in one of said test centers
Item
Treatment in one of said test centers
boolean
Adequate renal and hepatic function in accordance with the following definitions
Item
Adequate renal and hepatic function in accordance with the following definitions
boolean
Bilirubin Total: ≤ 3x upper reference value
Item
Bilirubin Total: ≤ 3x upper reference value
boolean
SGOT or SGPT: ≤ 3x upper reference value
Item
SGOT or SGPT: ≤ 3x upper reference value
boolean
Alkaline phosphatase: ≤ 5x upper reference value
Item
Alkaline phosphatase: ≤ 5x upper reference value
boolean
Creatinine i. S.: ≤ 2x the upper reference value
Item
Creatinine i. S.: ≤ 2x the upper reference value
boolean
Written informed consent of the patient or the legal representative
Item
Written informed consent of the patient or the legal representative
boolean
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Participate in this study at an earlier date
Item
Participate in this study at an earlier date
boolean
Serious psychiatric pre-/concomitant disease
Item
Serious psychiatric pre-/concomitant disease
boolean
Pregnancy or lactation
Item
Pregnancy or lactation
boolean
Women of childbearing age with insufficient or unsecured contraception
Item
Women of childbearing age with insufficient or unsecured contraception
boolean
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
Item
Proof of probable or proven invasive active Fungal infection at the time of study inclusion (see EORTC / MSG-defi nition)
boolean
Patient with pathological function parameters of liver and kidney function
Item
Patient with pathological function parameters of liver and kidney function
boolean
Total bilirubin:> 3x upper reference value
Item
Total bilirubin:> 3x upper reference value
boolean
SGOT or SGPT:> 3x upper reference value
Item
SGOT or SGPT:> 3x upper reference value
boolean
Alkaline phosphatase:> 5x the upper reference value
Item
Alkaline phosphatase:> 5x the upper reference value
boolean
Creatinine i. S.:> 2x upper reference value
Item
Creatinine i. S.:> 2x upper reference value
boolean
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
Item
Clinical and/or laboratory evidence of active veno-occlusive disease. VOD is characterized by an increase in serum transaminases and following a persistent increase in serum bilirubin and liver tenderness, weight gain and ascites
boolean
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
Item
Hemodynamically instablier patient or patient with an anticipated Survival time of <5 days
boolean
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
Item
Concomitant use of rifampicin, phenytoin, carbamazepine, phenobarbital, Dexamethasone, efavirenz and nevirapine
boolean
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
Item
Patient with a history of intolerance to echinocandin antifungals or documented allergic reactions to amphotericin B
boolean
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
Item
Any other condition or circumstance, that in the opinion of the attending physician pose a risk for the patient, impair the protocol-compliant therapy of the patient, and could affect the objective of the study
boolean
Missing or incomplete consent
Item
Missing or incomplete consent
boolean
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial